
The Federal zzso zzso and zzso Act and related regulations (21 zzso 301 et zzso give zzso staff the legal authority and responsibility to review the safety and effectiveness of drugs and biological products (including products used in cancer zzso from zzso testing through all zzso of clinical research and zzso zzso review activities in the zzso arena can be divided into five major zzso zzso initial review of zzso new drug zzso zzso zzso ongoing review of zzso research (including new research protocols submitted to existing zzso and zzso safety reports describing adverse events with the new zzso zzso discussions with commercial sponsors regarding their clinical development plans, including the design and conduct of key studies that are intended to support initial marketing approval for a new product or to support the addition of new indications to the prescribing information for currently marketed zzso zzso review of submitted new drug applications zzso or biological licensing applications zzso and zzso continuing review of the safety and effectiveness of marketed zzso Through these review activities, zzso staff work to ensure that products approved for marketing for cancer treatment are effective and adequately safe for their intended uses and to ensure that the quality, effectiveness, and safety of products on the market are preserved or zzso so patients and physicians may use these products with confidence and with adequate zzso Because these review activities generally fall into a zzso zzso the following discussion parallels the development course of a typical new zzso 

